| 产品名称: | Mycobacterium smegmatis (Trevisan) Lehmann and Neumann |
|---|---|
| 商品货号: | TS199879 |
| Application: | Produces antitumor immunity stimulant Produces vaccine adjuvant Preparation of non-specific stimulant for antitumor immunity |
| Biosafety Level: | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format: | freeze-dried |
| Disclosure: | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®: | no |
| Type Strain: | no |
| Medium: | ATCC® Medium 905: Petragnani medium |
| Growth Conditions: | Temperature: 37.0°C |
| Name of Depositor: | Wallace Laboratories |
| U.S. Patent Number: | |
| Chain of Custody: | ATCC < |
| References: | Berger FM, et al. Process for preparing vaccine adjuvant. US Patent 4,036,953 dated Jul 19 1977 Adam A, et al. Agents effective as non-specific stimulants for antitumoral immunity derived from micro-organisms of the mycobacteria type and methods for their manufacture. US Patent 3,876,779 dated Apr 8 1975 |